Tulixone TZ 500mg/62.5mg Injection
Marketer
Tulip Lab Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Tulixone TZ 500mg/62.5mg Injection
Combiflox TZ 500 mg/62.5 mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be solely under a physician's guidance; strictly adhere to the prescribed dosage schedule. Complete the full treatment course, even with symptom improvement, as premature cessation may compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects warrant immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) necessitate prompt emergency care. Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid operation of vehicles if experiencing somnolence or vertigo. Adequate rest, a nutritious diet, and ample hydration will promote faster recovery. Your doctor may order laboratory and imaging tests to monitor treatment response.
Uses of Tulixone TZ 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Tulixone TZ 500mg/62.5mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Tulixone TZ 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Tulixone TZ 500mg/62.5mg Injection:
Administering this medication will be handled by your physician or registered nurse; please refrain from self-medicating.
How Tulixone TZ 500mg/62.5mg Injection works:
Ceftriaxone/Tazobactum injection (Tulixone TZ 500mg/62.5mg) combines a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their growth. Tazobactum counteracts bacterial resistance mechanisms, thus amplifying Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
No adverse reactions are associated with the concomitant use of alcohol and Tulixone TZ 500 mg/62.5 mg Injection.
PregnancySAFE IF PRESCRIBED
Administering Tulixone TZ 500 mg/62.5 mg Injection during pregnancy is typically viewed as safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; despite this, data from human clinical trials remains scarce.
Breast feedingCAUTION
Administering Tulixone TZ 500 mg/62.5 mg Injection to breastfeeding mothers requires careful consideration. Nursing should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Tulixone TZ 500 mg/62.5 mg Injection could lead to drowsiness, blurred vision, and dizziness. Driving is inadvisable while experiencing these effects.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Tulixone TZ 500 mg/62.5 mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
For individuals with severe hepatic impairment, administering Tulixone TZ 500 mg/62.5 mg Injection requires careful consideration and potential dosage modification. Patients with mild to moderate liver disease do not require dosage alterations of Tulixone TZ 500 mg/62.5 mg Injection. Physician consultation is advised.
What if you forget to take Tulixone TZ 500mg/62.5mg Injection :
Omitting a scheduled dose of Tulixone TZ 500 mg/62.5 mg Injection necessitates contacting your physician.
Facts to Know About Tulixone TZ 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently